Skip to content

Changes in the wound microbiome and their impact on chronic wound healing under hyperbaric conditions

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523863-39-00
Enrollment
80
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic wounds

Brief summary

The primary endpoint will be the between-group difference in wound microbiome alpha-diversity at the prespecified primary evaluation time point Week 6 (end of the 6-week HBOT intervention period), quantified by the Shannon diversity index (confirmatory primary endpoint)., microbial diversity and composition within the wound microbiome will be assessed longitudinally before, during, and after the HBOT treatment period

Detailed description

• Clinical wound healing indicators (e.g., wound size reduction, infection rates, tissue regeneration quality)., • A structured biobank of microbiome samples and metadata from chronic wounds to enable future research on wound healing, resistance mechanisms, and HBOT-related microbial responses., • Patient-reported outcomes on quality of life and wound-related pain or discomfort., • Cost-effectiveness assessment of HBOT relative to conventional wound care.

Interventions

Sponsors

Medical University Of Graz
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be the between-group difference in wound microbiome alpha-diversity at the prespecified primary evaluation time point Week 6 (end of the 6-week HBOT intervention period), quantified by the Shannon diversity index (confirmatory primary endpoint)., microbial diversity and composition within the wound microbiome will be assessed longitudinally before, during, and after the HBOT treatment period

Secondary

MeasureTime frame
• Clinical wound healing indicators (e.g., wound size reduction, infection rates, tissue regeneration quality)., • A structured biobank of microbiome samples and metadata from chronic wounds to enable future research on wound healing, resistance mechanisms, and HBOT-related microbial responses., • Patient-reported outcomes on quality of life and wound-related pain or discomfort., • Cost-effectiveness assessment of HBOT relative to conventional wound care.

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 17, 2026